First U.S. Trachea Transplant Patient Breathing Freely
TUESDAY, April 6, 2021 -- A woman who received the first trachea transplant in the United States could be a model for other patients, including those with birth defects, those with untreatable airway diseases, and COVID-19 survivors left with serious windpipe damage from breathing machines.
Sonia Sein's trachea was damaged after extensive treatment for severe asthma, and she said she had spent the last six years "trying to catch every breath at every moment," the Associated Press reported. But she is recovering at home and breathing freely again after the 18-hour procedure in January at Mount Sinai in New York City. The patient is taking medications to prevent organ rejection, but doctors hope she may eventually be able to stop taking them. So far, Sein has not had any complications or signs of rejection.
While experts say it is too early to know whether the transplant was a total success, if "it was going to be a failure, we would know by now. It's quite promising," Alec Patterson, M.D., a transplant surgeon at Washington University in St. Louis, who was not involved in the operation, told the AP. "It's a major step forward."
A trachea transplant is challenging and would only be considered as a last resort, according to experts.
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Read this next
WEDNESDAY, April 21, 2021 -- Cavity shave margin (CSM) resections may reduce positive margin rates in patients with pure ductal carcinoma in situ (DCIS), according to a study...
TUESDAY, April 13, 2021 -- COVID-19 infection is an independent risk factor for surgical mortality, according to a research letter published online April 12 in JAMA Network...
TUESDAY, March 30, 2021 -- Self-reported data via text messaging revealed that patients did not use about 60 percent of prescribed opioid tablets following common orthopedic or...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.